AU526239B2 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU526239B2
AU526239B2 AU42041/78A AU4204178A AU526239B2 AU 526239 B2 AU526239 B2 AU 526239B2 AU 42041/78 A AU42041/78 A AU 42041/78A AU 4204178 A AU4204178 A AU 4204178A AU 526239 B2 AU526239 B2 AU 526239B2
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU42041/78A
Other languages
English (en)
Other versions
AU4204178A (en
Inventor
P. Horovitz And Bernard Rubin Zola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU526239(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of AU4204178A publication Critical patent/AU4204178A/en
Application granted granted Critical
Publication of AU526239B2 publication Critical patent/AU526239B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU42041/78A 1977-12-27 1978-11-29 Pharmaceutical compositions Expired AU526239B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27
USUS864428 1977-12-27

Publications (2)

Publication Number Publication Date
AU4204178A AU4204178A (en) 1979-07-05
AU526239B2 true AU526239B2 (en) 1982-12-23

Family

ID=25343256

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42041/78A Expired AU526239B2 (en) 1977-12-27 1978-11-29 Pharmaceutical compositions

Country Status (30)

Country Link
JP (1) JPS54110333A (de)
AR (1) AR230378A1 (de)
AU (1) AU526239B2 (de)
BE (1) BE873092A (de)
CA (1) CA1120400A (de)
CH (1) CH642542A5 (de)
DE (1) DE2854316C3 (de)
DK (1) DK578778A (de)
EG (1) EG14178A (de)
FI (1) FI783991A (de)
FR (1) FR2413089A1 (de)
GB (1) GB2010675B (de)
GR (1) GR72951B (de)
HK (1) HK45483A (de)
HU (1) HU178747B (de)
IE (1) IE48306B1 (de)
IL (1) IL56281A (de)
IT (1) IT1202811B (de)
KE (1) KE3235A (de)
LU (1) LU80709A1 (de)
MY (2) MY8300240A (de)
NL (2) NL192870C (de)
NO (1) NO784357L (de)
NZ (1) NZ189159A (de)
PH (1) PH22111A (de)
PL (1) PL212188A1 (de)
PT (1) PT68983A (de)
SE (1) SE445173B (de)
SG (1) SG41482G (de)
ZA (1) ZA786948B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
PL212188A1 (de) 1980-02-11
AR230378A1 (es) 1984-04-30
EG14178A (en) 1984-06-30
PH22111A (en) 1988-06-01
IE48306B1 (en) 1984-12-12
PT68983A (en) 1979-01-01
NZ189159A (en) 1984-12-14
CA1120400A (en) 1982-03-23
MY102991A (en) 1993-03-31
CH642542A5 (de) 1984-04-30
GB2010675B (en) 1982-06-16
IE782413L (en) 1979-06-27
NL192870B (nl) 1997-12-01
JPS647045B2 (de) 1989-02-07
FI783991A (fi) 1979-06-28
FR2413089B1 (de) 1980-12-26
DE2854316C2 (de) 1989-08-10
DE2854316C3 (de) 1994-12-22
HK45483A (en) 1983-10-28
GR72951B (de) 1984-01-17
IL56281A0 (en) 1979-03-12
NL980017I1 (nl) 1998-07-01
LU80709A1 (de) 1979-04-13
JPS54110333A (en) 1979-08-29
HU178747B (en) 1982-06-28
MY8300240A (en) 1983-12-31
GB2010675A (en) 1979-07-04
DK578778A (da) 1979-06-28
IT7831266A0 (it) 1978-12-22
FR2413089A1 (fr) 1979-07-27
SG41482G (en) 1985-01-11
DE2854316A1 (de) 1979-07-05
SE7813277L (sv) 1979-06-28
ZA786948B (en) 1980-04-30
BE873092A (fr) 1979-06-27
AU4204178A (en) 1979-07-05
IT1202811B (it) 1989-02-09
IL56281A (en) 1983-05-15
KE3235A (en) 1982-11-05
SE445173B (sv) 1986-06-09
NL192870C (nl) 1998-04-02
NL7812164A (nl) 1979-06-29
NO784357L (no) 1979-06-28

Similar Documents

Publication Publication Date Title
AU525089B2 (en) Pharmaceutical compositions
ZA781398B (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
AU535604B2 (en) Pharmaceutical compositions
AU514703B2 (en) Zootechnic compositions
AU526239B2 (en) Pharmaceutical compositions
GB2008403B (en) Pharmaceutical compositions
AU535605B2 (en) Pharmaceutical compositions
MW478A1 (en) Pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
ZA78387B (en) Pharmaceutical compositions
GB2008408B (en) Pharmaceutical compositions
AU6501980A (en) Pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
NZ188040A (en) 1-phenylethanolamine derivatives pharmaceutical compositions
GB1556851A (en) Pharmaceutical compositions
ZA782736B (en) Pharmaceutical compositions
AU523405B2 (en) Pharmaceutical compositions
GB2006010B (en) Pharmaceutical compositions
AU3888678A (en) Pharmaceutical compositions comprising 2-cyanaziridine
AU512612B2 (en) Pharmaceutical compositions
AU534571B2 (en) Pharmaceutical compositions
ZA783746B (en) Pharmaceutical compositions